{"id":"W2160875391","doi":"10.3747/co.21.1647","title":"Learning Experiences with Sunitinib Continuous Daily Dosing in Patients with Pancreatic Neuroendocrine Tumours","year":2014,"lang":"en","type":"review","venue":"Current Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Pfizer","keywords":"Sunitinib; Medicine; Everolimus; Dosing; GiST; Tyrosine-kinase inhibitor; Neuroendocrine tumors; Oncology; Renal cell carcinoma; Internal medicine; Vascular endothelial growth factor; Schedule; Clinical trial; Pharmacology; Stromal cell; VEGF receptors; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001855158,0.0007715847,0.003726541,0.0007271043,0.0001254054,0.00005205366,0.0003983847,0.00002988,0.0001015422],"category_scores_gemma":[0.000774061,0.0004974836,0.0001833748,0.000803572,0.0005447068,0.0001540313,0.0001896656,0.002249703,0.00004565218],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003726239,"about_ca_system_score_gemma":0.0008022153,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001855287,"about_ca_topic_score_gemma":0.00003846958,"domain_scores_codex":[0.9950428,0.001091612,0.0009189792,0.001009653,0.0007488365,0.001188128],"domain_scores_gemma":[0.9972193,0.000845954,0.0007721924,0.0005132155,0.0002483937,0.0004010091],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007620116,0.001022433,0.06645624,0.01265068,0.00007890256,0.004920214,0.0003623617,0.000002835665,9.914988e-8,0.000009348086,0.0002146757,0.9135202],"study_design_scores_gemma":[0.005190922,0.01146208,0.001181108,0.01792409,0.0006249759,0.0020772,0.001064174,0.000005960836,0.000001691808,0.000001266987,0.9599649,0.0005016841],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1961911,0.7992667,0.000008182147,0.00006503928,0.0004908913,0.002951125,0.000008173134,0.0001418645,0.0008769601],"genre_scores_gemma":[0.03295298,0.9643734,0.000166083,0.0000452033,0.0003494424,0.001226173,0.000362451,0.0001971899,0.0003270719],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9597502,"threshold_uncertainty_score":0.9997477,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06708898796358823,"score_gpt":0.4121968264952486,"score_spread":0.3451078385316604,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}